First human trial of COVID-19 vaccine finds it is safe: The Lancet
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new Chinese research published in the medical journal, The Lancet. The study involved trial among 108 healthy adult